Silver Sponsor

IsoPlexis, a privately held life sciences company, is developing novel technologies at the forefront of cell therapy and immune-based treatments of cancer. Using our secreted proteomic platform to identify patient responses at the single cell level, IsoPlexis' original scientific leaders from Yale, Caltech, UCLA, and Memorial Sloan Kettering Cancer Center are advancing the understanding of personalized therapies against cancer.


Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington


To Sponsor Or Exhibit

Marc Rhys-Evans
+44 20 7827 5945




To Register

Tayyab Abbasi
+44 20 7092 1210




Press Relations

Karina Kusova
+44 20 7092 1071